Andere talen PCL, Inc.

Aandelen

A241820

KR7241820000

slotkoers Korea S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.203 ^KRW	+0,50%		-1,80%	-66,44%

2023	Zuid-Koreaanse aandelen sluiten lager door aanhoudende onzekerheid over overeenkomst over schuldenplafond in VS; PCL verliest 13%.	MT
2023	PCL, Inc. rapporteert resultaten voor het volledige jaar eindigend op 31 december 2022	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets	16/01
PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets	26/12
PCL, Inc. announced that it expects to receive KRW 9.99999885 billion in funding from Global Emerging Markets	21/12
PCL, Inc. announced that it expects to receive KRW 9.99999838 billion in funding from Global Emerging Markets	15/12
South Korean Stocks Close Lower as Uncertainties Around US Debt Ceiling Deal Remain; PCL Loses 13%	31-05-23
PCL to Raise 36 Billion Won via Share Issuance	31-05-23
PCL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
PCL, Inc. announced that it has received KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	29-12-22
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%	22-12-22
PCL, Inc. announced that it expects to receive KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.	21-12-22
PCL, Inc. terminated the acquisition of 40.76% stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd.	12-12-22
PCL, Inc. announced that it has received KRW 12.060247575 billion in funding	12-12-22
OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.	11-11-22
PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.	11-11-22
PCL, Inc.(KOSDAQ:A241820) dropped from S&P Global BMI Index	07-04-22
PCL, Inc.(KOSDAQ:A241820) added to S&P Global BMI Index	20-09-21
MCureX Therapeutics, Inc. announced that it expects to receive KRW 2 billion in funding from OliX Pharmaceuticals,Inc, PCL, Inc., Samyang Holdings Corporation	23-06-21
PCL, Inc. announced that it has received KRW 40.499938368 billion in funding from a group of investors	25-03-21
Datametrex AI Limited Secures Authorization by Health Canada for PCL Inc.'s COVID19 Rapid Antigen Test Kit	23-03-21
PCL, Inc. announced that it expects to receive KRW 40.499938368 billion in funding from a group of investors	18-03-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PCL, Inc.

Aandelen

A241820

KR7241820000

Andere talen

Filters